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ABSTRACT : To quantitate the effects of biliary decompression on hepatic functional 
reserve before operation in patietns with obstructive jaundice, we developed a new method 
of maximal hepatic removal of indocyanine green in the bile (ICG Bmax). This was 
calculated from the peak ICG concentration in the bile and the peak concentration time 
after its administration via antecubital vein using regression analysis. 
 This study involved 13 normal controls and 26 jaundiced patients. ICG Bmax of the 
normal controls indicated more than 0.5. Among the jaundiced patients. 17 showed an 
ICG Bmax value of more than -0.5 early during biliary decompression and 87% of them 
satisfactorily tolerated further radical operation. The remaining patients in whom ICG 
Bmax initially showed less than -0.5, but 67% of them had an unfavorable outcome 
postoperatively. Six of the nine patients whose ICG Bmax was less than -0.5 prior to 
operation suffered severe postoperative complication, and three of whom died from hepatic 
failure. These results indicated that ICG Bmax evaluation during an early period of biliary 
decompression provided a reliable asseessment of the effects and a prediction of biliary 
drainage. ICG Bmax evaluation is also useful to the timely decision of radical operation.
       INTRODUCTION 
 Two-step surgery comprising preliminary 
biliary decompression followed by a radical 
operation after improvement of jaundice has 
become a common surgical treatment for ob-
structive jaundice.'-3) However, in some cases, 
biliary decompression may , provide only a 
limited relief of jaundice, and complications will 
develop subsequent to the radical operation.4,s) 
 Although reliable indexes predictively evaluat-
ing biliary decompression effects and prognosis 
are indispensable, they have not yet been 
established. Indocyanine green (ICG) has long
been used to measure hepatic function.''') We 
have previously evaluated hepatic removal of 
ICG in the bile by using an external T-tube in 
patients with common bile duct stones, 
observing the appearance of ICG in the bile for 
about 15 minutes after injecting the dye and a 
peak biliary ICG concentration for about 2 
hours.') We have also observed that ICG 
appeared in the bile late and its concentration 
was lower in jaundiced patients a few days after 
biliary decompression. However, ICG appeared 
earlier and the concentration increased with 
recovery of the hepatic function. 
 We have devised a new method to calculate 
the maximal hepatic removal rate in the bile
(ICG Bmax) and report its usefulness for 
evaluating the effects of biliary decompression 
on relieving jaundice and establishing the 
prognosis.
   MATERIALS AND METHODS 
 Twenty-six patients who underwent biliary 
decompression for obstructive jaundice at the 
Second Department of Surgery, Nagasaki Uni-
versity Hospital, were involved for this study. 
Among these patients three had malignant 
neoplasms ; three others included one with 
chronic pancreatitis, one with intrahepatic 
stones, and one with choledocholithiasis. 
Thirteen non-jaundiced patients with chole 
lithiasis who underwent cholecystectomy and 
external T-tube drainage of common bile duct 
comprised control studies ; their liver functions 
were within normal limits. 
Measurement of ICG Bmax 
 After collecting a baseline bile sample early 
in the morning, 0.5 mg/kg body weight of ICG 
(Diagnogreen, Daiichi Seiyaku Co., Tokyo) was 
injected via the antecubital vein in patients who 
had fasted overnight. The bile was collected 
at 15-minute intervals for 6 hours in light-
shielded test tubes. Each sample of bile (0.1 
ml.) was diluted with 2.9 ml. of normal saline 
solution, and the concentration of ICG was then 
measured by clinical s p ectro photometry (Uvidec 
77, Japan spectroscopic Co. Ltd.) at 805 nm 
within 24 hours after sample collection. ICG 
Bmax was calculated from the peak ICG 
concentration in the bile and the peak 
concentration time by regression analysis as 
described by Barber at at.') ICG Bmax 
evaluation was carried out 84 times in these 
patients. 
Calculation of ICG Bmax 
 Patients undergoing percutaneous trans-
hepatic biliary drainage (PTBD) for obstructive 
jaundice showed low biliary ICG concentration 
and delayed appearance of the dye in the bile 
early during biliary decompression. Progressive 
improvement of hepatic functions by biliary 
decompression, bile concentration and appear-
ance of ICG in the bile heightened and hastened
Fig. 1. ICG concentration in the bile and 
        caluculated ICG hepatic removal rate on 
        the 1st, 7th and 14th day after T-tube
        drainage in a case of benign biliary 
         obstruction. Control represented a case of 
        choledocholithiasis without jaunduice
(Fig. 1). This phenomenon can be expressed 
by two factors : the maximum biliary ICG 
concentration and the time of the peak ICG 
concentration (peak concentration time). 
 The values of ICG concentration were plotted 
in semilogarithmic coordinates to evaluate a 
wide range of concentration. Peak concentration 
was determined by 6-hour serial measurement 
after administration of ICG of 0.5 mg/kg. 
    ICG Bmax (1)= log c t 
     c : peak biliary concentration 
     t : peak concentration time 
 With this formula, ICG concentrations of 1 
mg/dl or greater are graphically represented as 
positive values, but those less than 1 mg/dl as 
negative values (Fig. 1). Therefore, the formula 
was converted by multiplying the peak 
concentration values by 10 so that all plots 
converge at 0.1 mg/dl ICG and 0 hour. 
    ICG Bmax (2)= log (lox c) t 
 Since ICG Bmax (2) is never less than 0.1 mg/ 
dl, the slope of this formula is always positive. 
ICG Bmax (2) was further converted to natural
Fig. 2. Graphic representation of caluculated ICG 
       Bmax
logarithms for greater ease of the use of the 
values in subsequent analyses. (Fig. 2) 
    ICG Bmax=Loge { loge (10 X c) 
t 
 By this formula, ICG Bmax value changes
     Table 1. ICG Bmax in Control Group 
       Drainage Peak Time Peak Time ICG Bma
x       Procedure (hour) (mg/dl) 
1. A T-tube 2.0 32.3 1.10 
2. A T-tube 2.75 16.9 0.62 
3. B T-tube 1.5 11.3 1.20 
4. A T-tube 1.75 11.6 1.00 
5. B splint-tube 1.25 11.3 1.30 
6. A T-tube 1.5 20.4 1.30 
7. A T-tube 1.5 26.3 1.30 
8. C splint-tube 2.0 29.5 1.70 
9. A T-tube 1.75 32.8 1.20 
10. B T-tube 2.5 19.1 0.74 
11. A T-tube 1.5 8.0 1.10 
12. A T-tube 2.0 29.4 1.00 
13. A T-tube 2.5 22.7 0.76
serially form negative to positive as the peak 
concentration increases or the peak concen-
tration time is reduced.
          RESULTS 
 The control group showed maximum ICG 
concentration ranging from 8 to 33 mg/dl 
(mean± SD, 20.1±8.2 mg/dl) and peak 
concentration time form 1.25 to 2.75 hours (1.9± 
0.4 hours). All patients in this group showed 
ICG Bmax greater than 0.5 (1.1±0.27). 
Twenty-six patients with obstructive jaundice 
were categorized into three groups according to 
the level of ICG Bmax values early during biliary 
decompression : 
 1. Markedly Low ICG Bmax Group (ICG 
 Bmax <-0.5) 
 ICG Bmax values were considered to be 
 markedly low when they were -0.5 or less. 
 Nine of the 26 patients were included in this 
 group (Table 2). In this group, the total 
 bilirubin level ranged from 7.5 to 30.8 mg/dl 
 with a mean of 19.91 mg/dl. The peak ICG 
 concentration in the bile ranged from 0.305 to 
 1.74 mg/dl with a mean of 0.689 mg/dl. The 
 ICG Bmax was form -1.7 to -0.8 with a mean 
 of -1.3±0.41. Eight of these nine patients 
 responded poorly to further biliary decom-
 pression. Six of the eight patients who 
 evidence minor improvement in ICG Bmax 
 values prior to the radical operation had 
 severe postoperative complications, three of 
 whom died from hepatic failure. Only three 
 among this group survived without 
 postoperative complication. 
 2. Moderately Low ICG Bmax Group (0> 
 Bmax >_-0.5) 
 ICG Bmax values were considered to be 
 moderately low when they range between -0.5 
 and 0. Seven patients belonged to this group 
 (Table 3). In these patients, the total bilirubin 
 level varied from 7.0 to 25.7 mg/dl with a mean 
 of 15.5mg./dl. The peak ICG concentration 
 range from 1.19 to 5.35 mg./dl (mean value 2.90 
 mg/dl). The mean ICG Bmax was -0.33. In 
 this group, four of the seven patients showed 
 prolonged jaundice in spite of biliary 
 decompression, and one of the two who had
         Table 2. Operative Morbidity of Very Low ICG Bmax group (ICG Bmax<-0.5) 
         immediately after before 
        biliary decompression radical operation prolonged repeated operative 
       T.B. mg/dl ICG Bmax T.B. mg/dl ' ICG Bmax jaundice cholangitis morbidity 
1. B 21.1 -1.70 23.0 1.90 + - death 
2. B 29.0 -1.20 41.3 -2.00 + + death 
3. G 10.2 -0.66 14.5 -1.80 + + death 
4. C 7.5 -0.70 2.9 0.07 + - + 
5. D 9.6 -1.60 7.9 0.14 + + -
6. B 30.8 -1.60 7.8 -0.03 + + + 
7. B 26.0 -1.20 21.3 0.16 + + -
8. A 27.7 -0.85 15.6 -0.69 + - -
9. B 17.6 -0.85 10.5 -0.61 - - + 
        19.9±9.1 -1.3±0.41 16.1±11.4 -0.74±0.93 8/9,89% 5/9,56% 
      B : bile duct carcinoma D : choledocholithiasis 
      G : carcinoma of the gallbladder A : ampullary carcinoma
     Table 3. Operative Morbidity of Moderately Low ICG Bmax group (0<ICG Bmax<0.5) 
         immediately after before 
        biliary decompression radical operation prolonged repeated operative 
       T.B. mg/dl ICG Bmax T.B. mg/dl ICG Bmax jaundice cholangitis morbidity 
1. B 21.5 --0.19 5.9 0.85 + - + 
2. B 9.7 -0.38 2.1 -0.31 - - -
3. P 25.7 -0.46 5.3 -0.12 - - -
4. G 7.0 -0.41 1.3 0.15 -
5. G 20.0 -0.12 11.1 0.16 + + -
6. P 11.5 -0.40 8.0 0.52 + - death 
7. B 13.5 -0.34 3.8 0.78 + - -
        15.5±6.9 -0.33±0.13 5.3±3.4 -0.38±0.35 4/7,57% 1/7, 14% 
      G : carcinoma of the gallbladder B : bile duct carcinoma 
       P : carcinoma of the pancreas
          Table 4. Operative Morbidity of Higth ICG Bmax group (ICG Bmax<_0.5) 
         immediately after before 
        biliary decompression radical operation prolonged repeated operative 
       T.B. mg/dl ICG Bmax T.B. mg/dl ICG Bmax jaundice cholangitis morbidity 
1. H 12.8 0.34 2.2 -
2. B 14.6 0.42 2.1 1.10 -
3. P 8.1 0.30 3.5 0.55 - - -
4. B 8.2 0.26 1.9 - - -
5. B 19.9 0.72 3.5 0.46 - - -
6. P 12.2 0.34 2.5 1.00 - - -
7. G 10.7 0.15 4.1 0.28 - - -
8. P 23.5 0.23 3.9 0.37 - - death 
9. P 20.3 0.13 6.4 0.21 - - + 
10. A 25.6 0.42 15.3 -0.52 + - death 
       15.6±6.3 0.33±0.17 4.5±4.0 0.44±0.51 1/10,10% 1/10,10% 
      G : carcinoma of the gallbladder B : bile duct carcinoma 
      P : carcinoma of the pancreas A: ampullary carcinoma 
      H : hepatoma
 severe postoperative complications died from 
 hepatic failure. 
 3. High ICG Bmax Gorup (ICG Bmax >_0) 
 Ten patients comprixed this group (Table 4). 
 The total bilirubin level was from 8.1 to 25.6 
 mg/dl (mean 15.6 mg/dl). The peak ICG 
 concentration was 5.12 mg/dl (mean), and ICG 
 Bmax was 0.33±0.17. Although the total 
 bilirubin level in this group was similar to that 
 of the other two groups, nine of the ten 
 
-responded favorably to biliary decompression . 
 Two patients who responded well had 
 postoperative complications, one of whom 
 died from an unrelated cause. A patient who 
 failed to recover despite lengthy biliary 
 decompression died from hepatic failure. 
         DISCUSSION 
 Recent advances in imaging techniques have 
facilitated early and accurate diagnosis of 
obstructive jaundice. Percutaneous trans-
hepatic cholangiography (PTC) or percutaneous 
transhepatic bile duct drainage (PTCD) has also 
become a safe technique using ultrasound 
guidance. 10, 11) In patients with persistent ob-
structive j aundice,life-threatening postoperative 
complications will occur if this condition is not 
successfully treated prior to surgical inter-
vention. It has been well documented that 
radical operation for malignant obstructive 
jaundice should not be performed until total 
serum bilirubin decreases to a level below 5 mg/ 
dl by biliary decompression."') Therefore, 
alleviation of obstructive jaundice by using 
PTCD or cholecystostomy should be mandatory, 
especially in the case of hepatic hilar obstruction 
due to malignant tumor which requires 
extensive surgical treatment. However, in 
general, length of the decompression period 
tends to increase because of an unreasonable 
fear of postoperativ complications and lack of 
an accurate method to anticipate recovery of 
hepatic function by decompression, even for 
patients who are potentially rapidly responsive 
to decompression, often unnecessarily delaying 
operation. 
 To settle this problem, we examined the 
removal rate of indocyanine green in the bile
and found that this rate correlated well with 
recovery of impaired hepatobiliary function by 
decompression in patients with obstructive 
jaundice, and also that this removal rate at an 
early time during the decompression period 
enabled prediction of the varying effects of 
further biliary decompression. To simplify this 
effort, we employed the term of ICG Bmax 
expressed in natural logarithms by using two 
factors of peak ICG concentration in bile and 
peak ICG concentration time. 
 As to the impaired mechanism of bile 
excretion in the biliary tract in obstructive 
jaundice, Kojimal2) et al reported that the mito-
chondria in thesse impaired hepatic cells 
showed qualitative changes which also affected 
the energy dependet process of biliary ex-
creation. ICG is excreted competitively with 
bilirubin by the same mechanism.") These 
facts suggested that recovery of the impaired 
hepatic mechanism by biliary decompression in 
patients with obstructive jaundice could be 
monitored by examining serial changes of ICG 
excretion in the bile. In this study, improve-
ments occurred in all patients prior to the 
radical operation as compared with those 
observed immediately after biliary decom-
pression. However, improvement was notably 
limited in those patients with markedly low ICG 
Bmax group ; 89% responded poorly to biliary 
decompression (prolonged jaundice) in spite of 
preoperative external biliary drainage for more 
than 30 days. Moreover, 56% developed 
cholangitis preoperatively, and 67% experienced 
an unfavorable outcome. These facts clearly 
suggest that ICG Bmax values well reflected the 
effectiveness of the decompression procedure, 
and are useful not only for prognosis at an early 
period of decompression but also for evaluating 
effectiveness of biliary excretion. Consequently, 
weekly ICG Bmax evaluation will provide useful 
information for timing radical surgery in 
jaundiced patients. We believe that radical 
operation is contraindicated when ICG Bmax 
value is less than -0.5.
        CONCLUSION 
 ICG Bmax was highly sensitive to the degree 
of impairment of hepatic function in obstructive
jaundice. Examination immediately after biliary 
decompression allows early prediction of prog-
nosis, and serial evaluations by this technique 
in recovery of hepatic function enables early 
decision making regarding surgery. 
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